Image showing sections of cerebral brain organoids derived from pluripotent stem cells.
via Agnieszka Rybak-Wolf, MDC/LifeTime
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.
The LifeTime initiative, co-coordinated by the Max Delbrück Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Earlier detection and more effective treatment of diseases
To form a functioning, healthy body, our cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.
Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.
A detailed roadmap for implementing LifeTime
The perspective article “The LifeTime initiative and the future of cell-based interceptive medicine in Europe” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates ethically responsible research to benefit citizens all across Europe.
According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrück Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields – from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists – to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.”
Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for Covid-19. We hope EU leaders will realize we have to invest in the necessary research now.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell-based interceptive medicine
- Stem Cells News
Genetically Modified Pluripotent Stem Cells May Evade Immunological Rejection After Transplantation, Study Shows Jan. 11, 2024 — One of the biggest barriers to regenerative medicine is ...
- Cell Therapies, Vaccines May Work Better If T Cells Have More NAD(H)
“With more work, we also believe that this information could potentially be used to improve vaccine strategies and the response and durability of cell-based therapies used to treat cancer and ...
- Stem Cells in Reproductive Medicine
Check if you have access via personal or institutional login Stem cell science has the potential to impact human reproductive medicine significantly – cutting edge technologies allow the production ...
- Hijacking Viruses: Optimizing Lentivirus-Based Cell Engineering
Researchers commonly employ lentiviruses to modify cells genetically. However ... nucleic acid delivery applications and is establishing the future of science and medicine by developing products that ...
- The Problem with Shifting from ‘Evidence-Based’ to ‘Science-Based’ Medicine
where “scientific-based medicine” could have imposed mistaken and misguided orthodoxies. Embryonic-stem-cell research: During the great stem-cell debate of the early 2000s, we were told that ...
Go deeper with Google Headlines on:
Cell-based interceptive medicine
[google_news title=”” keyword=”cell-based interceptive medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
LifeTime Initiative
- 2024 Business of the Year special category honorees
Each of the 2024 Business of the Year honorees have enjoyed significant growth or market success over the past year. For some, 2023 was a continuation of years of ongoing success.
- Rutgers Board of Governors Approves Blau Wellness Center and Mental Health Fellowships
He is bestowing an endowment to create a fellowship program to train the next generation of mental health clinicians, the Rutgers University Board of Governors announced. Additionally, a building at ...
- Department of Community Development – Abu Dhabi unveils the 'Medeem' initiative
Medeem is an initiative launched by the government of Abu Dhabi, represented by the Department of Community Development - Abu Dhabi. The word “Medeem” was inspired by the traditional Emirati phrase ...
- JFK Elementary has a day of learning-- a lifetime of knowledge
Volunteers from Del Ar College and Texas A&M Corpus Christi showed up and showed out for the kinder and first-grade students over at JFK Elementary.
- F-35 program’s lifetime price tag tops $2 trillion, Pentagon wants jets to fly longer
While the Pentagon now expects the plane to fly until 2088, GAO found the services are planning to slash flight hours, which can help hold down the program's topline.
Go deeper with Google Headlines on:
LifeTime initiative
[google_news title=”” keyword=”LifeTime initiative” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]